|
News Feeds |
|
Liver Disease / Hepatitis News From Medical News Today
|
Latest Health News and Medical News posted throughout the day, every day.
|
-
Successful Completion Of First Clinical Trials On Potent New Hepatitis C Drug
The first clinical trials on a new investigational drug being developed to treat infections caused by Hepatitis C virus have been successfully completed...
-
NIH Awards $1.2 Million To Study Protein Misfolding Diseases
Three University of Massachusetts Amherst scientists have received a four-year, $1.2 million EUREKA grant from the U.S. National Institutes of Health (NIH) to study folding and misfolding of secretory proteins in the cell's protein factory, the endoplasmic reticulum, where misfolding can lead to diseases such as cystic fibrosis and liver cirrhosis...
-
New Partnership Forms To Address The Hepatitis B And C Epidemic In Europe
At least 23 million European Union (EU) citizens are currently living with hepatitis B or hepatitis C,[i] both cancer-causing viruses...
-
Inhibitex Successfully Completes Phase 1a Trial Of INX-189
Inhibitex, Inc. (Nasdaq: INHX), announced that it has successfully completed a Phase1a, first-in-man, single ascending dose trial of INX-189, its nucleotide polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV) infections. In this trial, 42 healthy volunteers received either a single oral dose of INX-189, ranging from 3 mg to 100 mg, or placebo...
-
Macmillan's Response To NICE Decision On Liver Cancer Drug
Responding to the decision by the National Institute for Health and Clinical Excellence (NICE) not to recommend sorafenib (Nexavar®) as a treatment for advanced liver cancer, Mike Hobday, Head of Campaigns at Macmillan Cancer Support, said: 'We are extremely disappointed that NICE has decided not to recommend sorafenib as a treatment for people with advanced liver cancer...
|
|
News Feeds